Login / Signup

Initial Experience of Vericiguat Treatment in Patients with Heart Failure and Reduced Ejection Fraction.

Makiko NakamuraTeruhiko ImamuraKoichiro Kinugawa
Published in: Journal of clinical medicine (2023)
Vericiguat therapy might be feasible and effective upon quadruple therapy for those with heart failure, although further investigation is warranted to validate our findings.
Keyphrases
  • heart failure
  • helicobacter pylori
  • helicobacter pylori infection
  • left ventricular
  • combination therapy
  • bone marrow
  • mesenchymal stem cells
  • replacement therapy
  • acute heart failure
  • smoking cessation